Eline Pottie

14PUBLICATIONS
47CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsCharacterisation of biological macromoleculesToxicology (incl. clinical toxicology)Biomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 01, 2026
N‑Benzyl-Tryptamine Derivatives as Serotonin 5‑HT2 Receptor Ligands: Synthesis and Structure-Affinity/Activity Relationships.

|Mar 20, 2026
N-Benzyl-tryptamine Derivatives as Serotonin 5-HT2A Receptor (5-HT2AR) Agonists: Focus on Different In Vitro 5-HT2AR Activity Profiles.

Eline Pottie, Emma Vertriest, Darío Martínez-Afani

|Nov 14, 2025
The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents.

Núria Nadal-Gratacós, Pol Puigseslloses, Laura Guzmán

|Nov 05, 2025
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects.

Dino Luethi, Grant C Glatfelter, Eline Pottie

|Oct 21, 2025
Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential.

Pol Puigseslloses, Núria Nadal-Gratacós, Berta Fumàs

|Aug 06, 2025
Setup and Evaluation of the TRACT Assay Principle for the In Vitro Functional Characterization of Modulators of the Serotonin Transporter and the Serotonin 2A Receptor.

Axelle Timmerman, Donna Walther, Michael H Baumann

Pageof 3

Frequent Collaborators

13 joint publications

Christophe Stove

3 joint publications

Annelies Cannaert

3 joint publications

Michael Decker

2 joint publications

David Pubill